These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 4603394)

  • 1. [Clinical application of rifampicin to common infections (author's transl)].
    Nakagawa K; Watanabe K; Suzuki T
    Jpn J Antibiot; 1974 Apr; 27(2):69-72. PubMed ID: 4603394
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinical evaluation of rifampicin for urinary tract infection].
    Kobayashi H; Takahashi Y; Sawanishi K; Tomoyoshi T; Matsuo M
    Hinyokika Kiyo; 1971 Jun; 17(6):429-42. PubMed ID: 4934923
    [No Abstract]   [Full Text] [Related]  

  • 3. Rifampicin, a general review.
    Binda G; Domenichini E; Gottardi A; Orlandi B; Ortelli E; Pacini B; Fowst G
    Arzneimittelforschung; 1971 Dec; 21(12):1907-77. PubMed ID: 4945790
    [No Abstract]   [Full Text] [Related]  

  • 4. [Rifampicin and colimycin in management of chronic infections of the kidneys and urinary tract (author's transl)].
    Palascák P; Skutil V; Záhradníková I
    Bratisl Lek Listy; 1979 Sep; 72(3):373-81. PubMed ID: 509284
    [No Abstract]   [Full Text] [Related]  

  • 5. Rifampicin plus nalidixic acid: a rational combination for the treatment of urinary infection.
    Greenwood D; Andrew J
    J Antimicrob Chemother; 1978 Nov; 4(6):533-8. PubMed ID: 101503
    [No Abstract]   [Full Text] [Related]  

  • 6. [A clinical observation of cefuroxime in pediatric field (author's transl)].
    Ohnuma K; Asuka N; Aoyama R; Nagata K
    Jpn J Antibiot; 1979 Nov; 32(11):1117-21. PubMed ID: 41955
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical experience with amikacin (BB-K8) (author's transl)].
    Nakagawa K; Watanabe K; Kabe J; Suzuki T; Koyama S
    Jpn J Antibiot; 1974 Jun; 27(3):337-42. PubMed ID: 4215897
    [No Abstract]   [Full Text] [Related]  

  • 8. [Clinical evaluation of cefazedon on patients with urinary tract infections (author's transl)].
    Lenzner A; Koch E
    Med Klin; 1979 May; 74(21):834-8. PubMed ID: 112365
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Value of rifampicin in treatment of the patients with bronchopulmonary lesions. A clinical-bacteriological study].
    Beeuwkes H; Buytendijk HJ; Maesen FP
    Arzneimittelforschung; 1969 Aug; 19(8):1283-5. PubMed ID: 4390183
    [No Abstract]   [Full Text] [Related]  

  • 10. [Treatment of urinary tract infections with amikacin (BB-K8) (author's transl)].
    Hirokawa I; Nakano I; Okada K; Higaki M; Akima S
    Jpn J Antibiot; 1974 Apr; 27(2):193-201. PubMed ID: 4603934
    [No Abstract]   [Full Text] [Related]  

  • 11. [Treatment of urinary tract infections in children. Clinical experience with minocycline granules (author's transl)].
    Hiraumi M; Tani J; Okamoto Y; Tada K
    Jpn J Antibiot; 1974 Dec; 27(6):730-4. PubMed ID: 4219032
    [No Abstract]   [Full Text] [Related]  

  • 12. [Clinical evaluation of rifampicin in urinary tract infections by double blind method].
    Hayashida K; Eto K; Shigematsu S
    Jpn J Antibiot; 1970 Aug; 23(4):411-5. PubMed ID: 4923673
    [No Abstract]   [Full Text] [Related]  

  • 13. [Comparison of antibacterial activity of oral antibacterial agents against recently isolated bacteria of E. coli, Klebsiella, Citrobacter and Proteus from clinical materials of urinary tract infection (author's transl)].
    Okamoto Y; Maehara K; Ueda Y; Nasu M; Kamiki T; Iri H; Nagai T; Kumamoto Y; Sakai S; Shigeta S; Kosaki N; Oguri T
    Jpn J Antibiot; 1981 Jun; 34(6):959-75. PubMed ID: 7026823
    [No Abstract]   [Full Text] [Related]  

  • 14. [Rifampicin in the treatment of urinary tract infections].
    Unno R; Yamamoto Y; Ishikawa H; Ogawa J; Ito S
    Kansenshogaku Zasshi; 1970 Mar; 43(12):416-22. PubMed ID: 4987128
    [No Abstract]   [Full Text] [Related]  

  • 15. [Resistance to rifampicin. In vitro and in vivo studies].
    Bouanchaud DH; Acar JF
    Pathol Biol (Paris); 1969; 17(15):763-7. PubMed ID: 4907911
    [No Abstract]   [Full Text] [Related]  

  • 16. [[Fundamental and clinical studies of amikacin (BB-K8) in surgical field (author's transl)]?].
    Shibata K; Fugii M; Shinagawa N; Suzuki Y; Muramatsu
    Jpn J Antibiot; 1974 Oct; 27(5):625-32. PubMed ID: 4218270
    [No Abstract]   [Full Text] [Related]  

  • 17. [Microbiological studies on the combination effect of rifampicin and nalidixic acid (author's transl)].
    Ishiyama M; Nakazawa S
    Jpn J Antibiot; 1974 Oct; 27(5):643-52. PubMed ID: 4218271
    [No Abstract]   [Full Text] [Related]  

  • 18. [Comparison of clinical effect between rifampicin and aminobenzylpenicillin in urinary tract infections by double blind method].
    Narahashi K; Momose S
    Hinyokika Kiyo; 1970 Dec; 16(12):781-6. PubMed ID: 4925066
    [No Abstract]   [Full Text] [Related]  

  • 19. [A double blind study of rifampicin].
    Nishiura T; Tamura M
    Hinyokika Kiyo; 1970 Oct; 16(10):619-23. PubMed ID: 4920593
    [No Abstract]   [Full Text] [Related]  

  • 20. [Rifampicin and its clinical use].
    Fafrowicz B
    Wiad Lek; 1971 Jul; 24(3):233-8. PubMed ID: 4926926
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.